Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 982 of 6351
-
ER-based program aims to stop opioid addiction before it starts in young people
Prevention CompletedThe purpose of the study is to develop and test innovative interventions to prevent the development of opioid misuse and opioid use disorders among older adolescents and young adults (AYA; ages 16-30) who use opioids, which will be initiated from a health care visit in the emerge…
Sponsor: University of Michigan • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC
-
Can a second treatment boost motor skills in SMA kids after gene therapy?
Disease control CompletedIn this study, researchers will learn more about the use of nusinersen (BIIB058) in participants with spinal muscular atrophy (SMA). This study will focus on children under the age of 3 who were previously treated with the gene therapy onasemnogene abeparvovec but are still facin…
Phase 4 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a simple shot help fight tough leukemia?
Disease control OngoingThe Phase I part of the study aims to evaluate the safety, efficacy, and tolerability of subcutaneous (SC) blinatumomab for treatment of Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL), to determine the maximum tolerated dose (MTD), and recommende…
Phase 1/2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Rectal cancer breakthrough: immunotherapy may replace surgery for some
Disease control Recruiting nowImmunotherapy has achieved significant therapeutic effect in DNA mismatch repair-deficient or microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC) , more than fifty percent of dMMR/MSI-H CRC patients might get pathological complete response(pCR) after PD-1 monoclo…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Gene test could revolutionize prostate cancer screening
Diagnosis OngoingAt the present moment, there is no international consensus on the optimal screening to perform in men with a specific genetic/molecular risk for PCa. The number of studies exploring screening strategies tailored to men with a family history for PCa is limited \[15-17\]: most of t…
Sponsor: Istituto Clinico Humanitas • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Triple therapy boosts survival in tough liver cancer cases
Disease control CompletedThe purpose of this study is to evaluate the safety and efficacy of hepatic arterial infusion chemotherapy (HAIC) in combination with PD-1 inhibitors and Lenvatinib in patients with high tumor burden advanced-stage hepatocellular carcinoma (HCC) with portal vein tumor thrombus (P…
Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Heart attack survivors: new drug may cut risk of another cardiac event
Disease control CompletedThe goal of this Target Trial Emulation (TTE) study is to evaluate the effect of evolocumab on clinical prognosis in patients with multivessel disease (MVD) following acute myocardial infarction (AMI) who have deferred non-culprit vessel. The main question it aims to answer is: …
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Stitch vs plug: new heart hole closure device tested to stop strokes
Disease control Recruiting nowSTITCH - Prospective Multi-Center Comparative Parallel Concurrent Study of the NobleStitch™ EL versus FDA-approved Amplatzer Occluder device for closure of Patent Foramen Ovale to prevent recurrent Ischemic stroke.
Sponsor: Nobles Medical Technologies II Inc • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a Couple's online Self-Help program heal COVID-19 PTSD?
Symptom relief CompletedPosttraumatic Stress Disorder (PTSD) will be a severe problem in Canada in the wake of COVID-19, especially for Military Members, Veterans, First Responders, and Healthcare Workers (MVFH). However, gold standard face-to-face PTSD treatments do not meet current MVFH needs, which r…
Sponsor: York University • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Rewiring the social brain: can a 16-Week program ease Autism's social struggles?
Symptom relief Recruiting now"Social brain" refers to brain regions dedicated to processing social information and enabling us to recognize and evaluate others' mental states. The social brain hypothesis suggests that our brains evolve to navigate complex social systems. The social brain is hypothesized to c…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
A glowing clue: light sensor may spot kidney damage in newborns
Diagnosis CompletedThis prospective, single-center observational cohort study evaluated whether continuous cerebral and bilateral renal near-infrared spectroscopy (NIRS) monitoring during therapeutic hypothermia distinguishes term neonates with hypoxic-ischemic encephalopathy (HIE) who develop acut…
Sponsor: Agah Bahadır Öztürk,MD • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
AI may decode kidney tumors from MRI scans, avoiding biopsies
Diagnosis Recruiting nowThis retrospective + prospective, non-interventional study aims to develop and evaluate artificial intelligence methods for the detection, pathological subtyping, and histological grading of renal tumors using magnetic resonance imaging (MRI). Approximately 900 adult patients wit…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
Can we break the vicious cycle of VEXAS syndrome?
Knowledge-focused CompletedVEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome (1/4,000 males aged \>50) is a paradigmatic age-onset acquired, severe, autoinflammatory hematological disease due to clonal dominance of hematopoietic cells bearing a somatic mutation in the UBA1 (ubiquiti…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
A pharmacist's touch: could structured medication reviews boost HIV treatment success?
Disease control CompletedThis clinical trial aims to evaluate the effectiveness and cost-effectiveness of two levels of a pharmacist-led Medication Therapy Management (MTM) program, Basic MTM and Enhanced MTM, compared with usual care for HIV patients at high risk of adverse drug events in Khartoum, Suda…
Sponsor: Universiti Sains Malaysia • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Reconnecting nerves during breast reconstruction may bring back sensation
Symptom relief CompletedA prospective study was conducted including patients undergoing nipple-sparing mastectomy with neurotization during expander-to-implant exchange between 2021 and 2025.
Sponsor: Hospital Angeles del Pedregal • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Which blood thinner is safer for lung clots? a Head-to-Head test
Disease control CompletedThis prospective, open-label, randomized controlled trial will compare clinically relevant bleeding during the first three months of treatment with apixaban versus rivaroxaban in adults with acute pulmonary embolism (PE) in a Pakistani cohort. A total of 540 participants will be …
Sponsor: Combined military hospital lahore • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Which ablation works best for AFib with heart failure? new trial aims to find out
Disease control OngoingAtrial fibrillation (AF) in the context of heart failure (HF) is associated with a markedly poor prognosis. Catheter ablation has been shown to improve outcomes in this population, enhancing ablation success rates in these patients is critical for further reducing morbidity and m…
Sponsor: Xu Liu • Aim: Disease control
Last updated Jun 26, 2026 13:54 UTC
-
Pacemaker trick may boost failing right heart in lung disease
Disease control Recruiting nowIn pulmonary arterial hypertension (PAH), progressive pulmonary vascular remodeling leads to supraphysiologic right ventricular (RV) afterload. Pharmacologic trials have shown that aggressive upfront treatment reversing pulmonary vascular remodeling successfully increases RV func…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for kids with kidney disease: rituximab cuts relapse risk
Disease control CompletedThis study investigated the combined impact of rituximab and targeted nursing care versus tacrolimus and targeted nursing care on efficacy, quality of life, adverse reactions, and recurrence rate in children with challenging (steroid-dependent or frequently relapsing) nephrotic s…
Sponsor: Wuhan Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a cancer drug stop liver tumors from returning after ablation?
Disease control CompletedFor early-stage hepatocellular carcinoma, i.e. Barcelona Clinical Liver Cancer Stage 0, ablation is the standard treatment with a comparable prognosis and less risk of ablation compared with liver resection. However, ablation is demanding on the surgeon and patients often face ea…
Sponsor: Chen Xiaoping • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC